A drug interaction study investigating the effect of Rifabutin on the pharmacokinetics of Maraviroc in healthy subjects - Ghannad, M.; Dennehy, M.; la Porte, C.; Seguin, I.; Tardiff, D.; Mallick, R.; Sabri, E.; Zhang, G.; Kanji, S.; Cameron, D. W. (PloS one, 2019)
Keywords: Acquired immune deficiency syndrome; Adolescent; Adult; Aged; AIDS; Anti-Bacterial Agents - pharmacokinetics; Antibacterial agents; Antiretroviral agents; Antiretroviral drugs; Biology and Life Sciences; Care and treatment; Chromatography; Cytochrome P-450; Dosage and administration; Drug dosages; Drug interaction; Drug Interactions; Epidemiology; Exposure; Female; Food; Health aspects; Healthy Volunteers; High performance liquid chromatography; HIV; HIV Fusion Inhibitors - pharmacokinetics; HIV infections; HIV patients; Hospitals; Human immunodeficiency virus; Humans; Infections; Liquid chromatography; Male; Maraviroc; Maraviroc - pharmacokinetics; Mass spectrometry; Mass spectroscopy; Medicine and Health Sciences; Middle Aged; Pharmacokinetics; Pharmacology; Rifabutin; Rifabutin - pharmacokinetics; Rifamycins; Spectroscopy; Steady state; Studies; Tissue Distribution; Tuberculosis; Young Adult; Canada; Ottawa Ontario Canada; Mexico